Non-opioid Pain Patch Market Players:
- Sanofi S.A.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GlaxoSmithKline Plc.
- Pfizer Inc.
- Clarion Brands
- Endo Pharmaceuticals
- TEH SENG Pharmaceutical
- Teva Pharmaceutical Industries Ltd.
- Teikoku Seiyaku Co. Ltd.
- Veridian Healthcare
- Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of non-opioid pain patch is estimated at USD 1.06 billion.
The global non-opioid pain patch market size crossed USD 998.64 million in 2025 and is likely to expand at a CAGR of over 6.4%, surpassing USD 1.86 billion revenue by 2035.
North America’s non-opioid pain patch market dominates with a 51% share by 2035, driven by the presence of key players leading to the development of new products.
Key players in the market include GlaxoSmithKline Plc., Pfizer Inc., Hisamitsu Pharmaceutical Co., Inc., Clarion Brands, Endo Pharmaceuticals, TEH SENG Pharmaceutical, Teva Pharmaceutical Industries Ltd., Teikoku Seiyaku Co. Ltd., Veridian Healthcare, Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
